Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Gore

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
British Journal of Cancer|October 11, 2001
The treatment of advanced renal cell cancer with high-dose oral thalidomideJ Stebbing, C Benson, T Eisen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
A phase II trial of ZD0473 in platinum-pretreated ovarian cancerM E Gore, R J Atkinson, H Thomas, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Ondansetron--a new safe and effective antiemetic in patients receiving high-dose melphalanC V Viner, P J Selby, G B Zulian, et al.
British Journal of Cancer|May 14, 1998
Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanomaS R Johnston, D O Constenla, J Moore, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 24, 2007
Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancerS Bishara, M Griffin, A Cargill, et al.
Clinical and Experimental Immunology|August 1, 1996
IL-12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL)D De Wit, C L Flemming, J D Harris, et al.
British Journal of Cancer|August 12, 2004
A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanomaS L Morris, S H Low, R P A'Hern, et al.
British Journal of Cancer|August 1, 1992
Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neckM E Gore, P Riches, K MacLennan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2003
Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free intervalM E Gore, R J Atkinson, H Thomas, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatinD R Newell, Z H Siddik, L A Gumbrell, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|October 11, 2001
The treatment of advanced renal cell cancer with high-dose oral thalidomideJ Stebbing, C Benson, T Eisen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
A phase II trial of ZD0473 in platinum-pretreated ovarian cancerM E Gore, R J Atkinson, H Thomas, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Ondansetron--a new safe and effective antiemetic in patients receiving high-dose melphalanC V Viner, P J Selby, G B Zulian, et al.
British Journal of Cancer|May 14, 1998
Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanomaS R Johnston, D O Constenla, J Moore, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 24, 2007
Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancerS Bishara, M Griffin, A Cargill, et al.
Clinical and Experimental Immunology|August 1, 1996
IL-12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL)D De Wit, C L Flemming, J D Harris, et al.
British Journal of Cancer|August 12, 2004
A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanomaS L Morris, S H Low, R P A'Hern, et al.
British Journal of Cancer|August 1, 1992
Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neckM E Gore, P Riches, K MacLennan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2003
Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free intervalM E Gore, R J Atkinson, H Thomas, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatinD R Newell, Z H Siddik, L A Gumbrell, et al.
Pageof 16